In a recently published clinical poster titled Utilizing a Business Case to Link Reduction in Infections to Reduction in Costs, a review of the literature indicated that expanding chlorhexidine gluconate (CHG) bathing beyond those at high risk to all patients can reduce hospital-acquired infection (HAI) rates. However, infection prevention strategies are often viewed as soft costs and difficult to fund despite HAI prevention being associated with significant cost avoidance.
Following an increase in Healthcare Associated Infections (HAIs) in the Oncology unit, St. Joseph Health Hospital presented a business case to leadership demonstrating a significant Return on Investment (ROI) to expand Hibiclens patient bathing beyond ICU and post- surgical patients to all patients house-wide. Results included a CLABSI reduction of 65% and other HAI decreases from 28%-100% resulting in a $514,739 cost avoidance.Download PDF
To download the PDF file for ‘Utilizing a Business Case to Link Reduction in Infections to Reduction in Costs’, please provide us with your contact information.